Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-71.57%
operating margin TTM
-65.2%
revenue TTM
29.17 Million
revenue per share TTM
0.97$
valuation ratios | |
|---|---|
| pe ratio | -12.03 |
| peg ratio | 0.45 |
| price to book ratio | 18.56 |
| price to sales ratio | 8.74 |
| enterprise value multiple | -13.05 |
| price fair value | 18.56 |
profitability ratios | |
|---|---|
| gross profit margin | 62.33% |
| operating profit margin | -65.2% |
| pretax profit margin | -71.46% |
| net profit margin | -71.57% |
| return on assets | -31.11% |
| return on equity | -140.96% |
| return on capital employed | -31.55% |
liquidity ratios | |
|---|---|
| current ratio | 5.79 |
| quick ratio | 4.88 |
| cash ratio | 3.75 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 204.55 |
| operating cycle | 282.39 |
| days of payables outstanding | 55.59 |
| cash conversion cycle | 226.80 |
| receivables turnover | 4.69 |
| payables turnover | 6.57 |
| inventory turnover | 1.78 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.68 |
| debt equity ratio | 3.37 |
| long term debt to capitalization | 0.77 |
| total debt to capitalization | 0.77 |
| interest coverage | 472.84 |
| cash flow to debt ratio | -0.40 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.90 |
| cash per share | 1.20 |
| operating cash flow per share | -0.87 |
| free cash flow operating cash flow ratio | 1.04 |
| cash flow coverage ratios | -0.40 |
| short term coverage ratios | -109.91 |
| capital expenditure coverage ratio | -26.14 |
Frequently Asked Questions
When was the last time ClearPoint Neuro, Inc. (NASDAQ:CLPT) reported earnings?
ClearPoint Neuro, Inc. (CLPT) published its most recent earnings results on 13-05-2026.
What is ClearPoint Neuro, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ClearPoint Neuro, Inc. (NASDAQ:CLPT)'s trailing twelve months ROE is -140.96%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ClearPoint Neuro, Inc. (CLPT) currently has a ROA of -31.11%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CLPT's net profit margin stand at?
CLPT reported a profit margin of -71.57% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CLPT's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.79 in the most recent quarter. The quick ratio stood at 4.88, with a Debt/Eq ratio of 3.37.